Across TCGA pan-cancer cohorts, LINC02085 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02085’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02085 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02085 is over-expressed in tumor.

BRCA, KIRC, and HNSC are the cancer types where LINC02085 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02085 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.012	.002	6	view →
KIRC	Male	All	+0.020	.037	1	view →
HNSC	All	III,IV	+0.009	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC02085 RNA expression & survival · all LINC02085 data types